Journal of Chemical and Pharmaceutical Research, 2012, 4(9): Research Article

Similar documents
MEDAK DIST. ANDHRA PRADESH STATE, INDIA. Research Article RECEIVED ON ACCEPTED ON

IJRPC 2011, 1(4) Rohan et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

DEVELOPMENT AND VALIDATION OF COLORIMETRIC METHODS FOR THE DETERMINATION OF RITONAVIR IN TABLETS

Journal of Chemical and Pharmaceutical Research

Development and validation of UV spectrophotometric estimation of lisinopril dihydrate in bulk and tablet dosage form using area under curve method

Method Development and Validation of Emtricitabine in Bulk by UV Spectroscopy

UV Spectrophotometric Estimation of Alprazolam by Area Under Curve And First Order Derivative Methods in Bulk and Pharmaceutical Dosage Form

Research Article Derivative Spectrophotometric Method for Estimation of Metformin Hydrochloride in Bulk Drug and Dosage Form

pharmaceutical formulations. Anagliptin shows absorption maximum at 246 nm and obeys beer s law in the

Journal of Chemical and Pharmaceutical Research, 2018, 10(2): Research Article

PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES

Journal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article

Development and validation of analytical methods for estimation of imatinib mesylate in bulk and solid dosage forms by UV spectroscopy

Comparative study of analytical method development of fluconazole in tablets and capsule by ultraviolet spectrophotometric method

Int. J. Pharm. Sci. Rev. Res., 31(1), March April 2015; Article No. 46, Pages:

Spectrophotometric Method for Estimation of Sitagliptin Phosphate in Bulk...

Development and Validation of Area Under Curve Method for Simultaneous Estimation of Thiocolchicoside and Lornoxicam in Tablet Dosage Form

Available Online through Research Article

210 J App Pharm Vol. 6; Issue 2: ; April, 2014 Mustafa et al, 2014

Development and validation of UV-visible spectrophotometric method for estimation of rifapentine in bulk and dosage form

Pelagia Research Library. Spectrophotometric method for simultaneous estimation of Valsartan and Hydrochlorothiazide in combined tablet dosage form

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-1, 2017, 1-7 Research Article Open Access.

Development and validation of spectrophotometric method for simultaneous estimation of Sumatriptan and Naproxen sodium in tablet dosage form

Available online Research Article

DEVELOPMENT OF NEW ANALYTICAL METHODS FOR THE ESTIMATION OF OPIOID ANTAGONIST NALTREXONE HYDROCHLORIDE

for Methotrexate. The result of analysis has been validated statistically and recovery studies confirmed the accuracy of

J Pharm Sci Bioscientific Res (4): ISSN NO

The present manuscript describes simple, sensitive, rapid, accurate, precise and cost effective First derivative

Development and Validation of a New Uv Method for the Analysis of Rebamipide


RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

DEVELOPMENT AND VALIDATION UV SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF ATENOLOL IN PURE MATERIALS AND PHARMACEUTICAL DOSAGE

Validated Spectrophotometric Method for Simultaneous Estimation of Atorvastatin and Nicotinic acid in Combined Pharmaceutical dosage form

World Journal of Pharmaceutical Research

UV SPECTROPHOTOMETRIC METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF ATENOLOL AND LOSARTAN POTASSIUM BY Q-ANALYSIS

Validated UV Spectrophotometric Method Development And Stability Studies Of Acamprosate Calcium In Bulk And Tablet Dosage Form

Pelagia Research Library

Department Of Quality Assurance Techniques, Modern College of Pharmacy Nigdi, Pune Maharashtra, India

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

M. SASIKALA* 1, M. TEJA DEEPTHI 2, K. VINOD KUMAR 3, NAGA MALLIKARJUNA RAJA B. 4 ABSTRACT KEYWORDS

First Order Derivative Spectrophotometric Method for Estimation of Melatonin in Bulk and Pharmaceutical Dosage Form

DEVELOPMENT OF UV SPECTROPHOTOMETRIC METHOD FOR THE ESTIMATION OF EZETIMIBE FROM TABLET FORMULATION

IJRPC 2013, 3(1) Gandhi et al ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

Development and Validation of a UV-Spectrophotometric Method for Quantification of Atorvastatin in Tablets

DEVELOPMENT AND VALIDATION OF AN UV- SPECTROPHOTOMETRIC METHOD FOR THE ESTIMATION OF FLUOXETINE IN PURE AND TABLET DOSAGE FORMS

UV-Spectrophotometric methods for estimation of Valsartan in bulk and tablet dosage form

Spectrophotometric Method for Simultaneous Estimation of Lopinavir and Ritonavir in bulk and tablet dosage form

Simultaneous UV Spectrophotometric Method For Estimation Of Ebastine And Montelukast Sodium In Tablet Dosage Form By Q-Ratio Method

DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF METOPROLOL SUCCINATE

Simultaneous estimation of amlodipine and losartan by UV-method in bulk drug and tablet dosage formulation

Asian Journal of Pharmacy and Life Science ISSN Vol.4 (2), April-June, 2014

Scholars Research Library. Der Pharmacia Lettre, 2016, 8 (3): (

International Journal of Pharma and Bio Sciences DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF STRONTIUM RANELATE IN SACHET

International Journal of Innovative Pharmaceutical Sciences and Research

4. VISIBLE SPECTROPHOTOMETRIC DETERMINATION OF. Fulvestrant is primarily used in the treatment of hormone receptor

Development and Validation of Stability Indicating HPTLC Method for Estimation of Seratrodast

Journal of Chemical and Pharmaceutical Research, 2017, 9(9): Research Article

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR CILOSTAZOL IN TABLET DOSAGE FORM

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

A New Stability-Indicating and Validated RP-HPLC Method for the Estimation of Liraglutide in Bulk and Pharmaceutical Dosage Forms

Research Article. ISSN Available online at 746

ISSN (Print)

Development and Validation of UV- Spectrophotometric Method for Estimation of Simvastatin in Bulk and Solid Dosage Form.

Available online Research Article

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS

International Journal of Innovative Pharmaceutical Sciences and Research

Research Article. Method Development of Antihypertensive Agent Using Official Dissolution Media

Guntur, India. *Corres. Mobile:

Scholars Research Library

ISSN (Print)

International Journal of Drug Research and Technology

A. Anton S et al. IRJP 1 (1)

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Tentu Nageswara Rao et al. / Int. Res J Pharm. App Sci., 2012; 2(4): 35-40

Journal of Chemical and Pharmaceutical Research

Development and Validation of RP-HPLC Method for the Estimation of Gemigliptin

Development and Validation of Ultraviolet-Spectrophotometric Method for the Determination of Tamsulosin

Journal of Pharmacreations

Development and Validation of A Spectrophotometric Method for Quantification and Dissolution Studies of Glimepiride in Tablets

International Journal of ChemTech Research CODEN( USA): IJCRGG ISSN : Vol.4, No.2, pp , April-June 2012

Observed amount of compound in sample % recovery = 100 Amount of all compound present in sample. The recovery values are summarized in Table 4.

Journal of Chemical and Pharmaceutical Research, 2018, 10(3): Research Article

Hyderabad, India. Department of Pharmaceutical Chemistry, Glocal University, Saharanpur, India.

UV VISIBLE SPECTROPHOTOMETRIC METHOD FOR THE SIMULTANEOUS ESTIMATION OF SERRATIOPEPTIDASE AND DICLOFENAC SODIUM IN THEIR BULK AND COMBINED DOSAGE FORM

THE PHARMA INNOVATION - JOURNAL. Difference Spectrophotometric Method for the Determination of Risperidone in Bulk and Tablet Dosage Form

Journal of Chemical and Pharmaceutical Research

UV-visible derivative spectroscopic method for simultaneous estimation of cefoperazone and tazobactam in injection dosage form

Spectrophotometric Estimation of Ganciclovir in Bulk Drug and its Formulation

Pankti M. Shah et al, Asian Journal of Pharmaceutical Technology & Innovation, 04 (17); 2016; 07-16

JPSBR: Volume 4, Issue 6: 2014 ( ) ISSN NO

UV-Visible Spectrophotometric Method for the Estimation of Rilpivirine Hydrochloride in Pharmaceutical Dosage Form by Using Multivariate Technique

Available Online through (or) IJPBS Volume 2 Issue 4 OCT-DEC Research Article Pharmaceutical Sciences

International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: Vol.7, No.2, pp ,

HPTLC Determination of Atomoxetine Hydrochloride from its Bulk Drug and Pharmaceutical Preparations

Journal of Chemical and Pharmaceutical Research

Corresponding Author:

Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences

L. Sriphong, A. Chaidedgumjorn, and K. Chaisuroj

Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Haloperidol and Trihexyphenidyl in API and Combined Tablet Dosage Form

Transcription:

Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2012, 4(9):4342-4351 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Development and validation of new colorimetric method for the estimation of oxybutynin chloride in bulk and dosage form *Rohit Patel, E. V. S. Subrahmanyam and A. R. Sharbaraya Department of Quality Assurance, Srinivas College of Pharmacy, Valachil, Mangalore. ABSTRACT An extractive colorimetric method has been developed for estimation of Oxybutynin chloride in its tablet form. Bromothymol blue indicator was used as the coloring agent, and a straw yellow color solution was formed in the presence of acidic medium after extracting the drug with chloroform. The solution absorbance was measured at 414 nm. The linearity range was in the range of 2.5-12.5 µg/ml. The validation of the new proposed method was carried out on various parameters like linearity, accuracy, precision, selectivity, specificity, robustness, and ruggedness, LOD, LOQ. Keywords: Oxybutynin chloride, extractive colorimetry, bromothymol blue, acidic medium, straw yellow color. INTRODUCTION A study of the interaction of light (or other electromagnetic radiation) with matter is an important and versatile tool for the chemist. Indeed, much of our knowledge of chemical substances comes from their specific absorption or emission of light. In this experiment, we are interested in analytical procedures based on the amount of light absorbed (or transmitted) as it passes through a sample. Drug category: Antimascarinic antagonist Chemical Structure: IUPAC Name: 4-Diethylaminobut- 2-ynyl2- cyclohexyl-2- hydroxy-2-phenyl-ethanoate Empirical formula: C 22 H 31 NO 3 Physical state: White to off-white crystaline powder Molecular mass: 357 gm/mol Solubility: Soluble in water, freely soluble in methanol, soluble in chloroform soluble in acid but not soluble in alkali 1a 4342

Oxybutynin is a belongs to class of antimuscarinic antagonist. Oxybutynin chloride relaxes bladder smooth muscle. In patients with conditions characterized by involuntary bladder contractions, cystometric studies have demonstrated that Oxybutynin chloride increases bladder (vesical) capacity, diminishes the frequency of uninhibited contractions of the detrusor muscle, and delays the initial desire to void. Oxybutynin chloride thus decreases urgency and the frequency of both incontinent episodes and voluntary urination 1b. Mechanism of action: 1c Oxybutynin has a dual mechanism of action. Contraction of the smooth muscle of the bladder is stimulated by the release of acetylcholine by the nerves within the bladder and the attachment of the acetylcholine to receptors on the surface of the muscle cells. Oxybutynin suppresses involuntary contractions of the bladder's smooth muscle (spasms) by blocking the release of acetylcholine. This is called an "anticholinergic effect." Oxybutynin also directly relaxes the bladder's outer layer of muscle (the detrusor muscle). The aim of study is here to developed new colorimetric method. Analysis of the drug is important for development of drugs in their formulation and their use in therapies, for which we require standard analytical procedures. The USP has published specific guidelines for method 4validation for compound evaluation. USP defines eight steps for validation: Accuracy, Precision, Specificity, Limit of detection, Limit of quantitation, Linearity and range, Ruggedness, Robustness. As quality control process is not static some form of validation/verification should continue till the validated procedure is in use. It should not be a concept that once the method is initially developed and validated it is forgotten. EXPERIMENTAL SECTION 1.0 MATERIALS AND METHODS A extractive colorimetric method was developed for oxybutynin chloride by using bromothymol blue, chloroform and hydrochloric acid. 1.1 Experiment: Reagents and Chemicals: Instruments and Apparatus: Apparatus and Glassware: Oxybutynin chloride(pure drug), Chloroforn, bromothymol blue (BTB), 0.1 N HCL Shimadzu, UV Spec-17 Jasco V-630 spectrophotometer, Essae weighing balance Weighing Balance, Sonicator, Separating funnel (250 ml capacity) 100ml, 50ml, 10ml Volumetric Flask 10ml, 5ml, 1ml Pipettes, 500ml, 250ml Beakers Others: Spatulas, Whattman Filter Papers, 1.2 Preparation of 1st standard stock solution of Oxybutynin chloride (1mg/ml): Stock solution of Oxybutynin chloride was prepared by accurately weighing 100mg of pure drug into a 100 ml volumetric flask and dissolved it in a 25 ml of chloroform and the volume was made up to the mark with chloroform to get a concentration of 1 mg/ml. 1.3 Preparation of 2 nd standard stock solution of Oxybutynin chloride (50µg/ml): The 2st standard stock solution of Oxybutynin chloride was prepared by pipetting out 5 ml of the 1st standard stock solution into a 100 ml volumetric flask and the volume was made up to the mark with chloroform to get a concentration of 200µg/ml. 4343

1.4 Preparation of working standard solutions (5-25µg/ml): The working standard solution of Oxybutynin chloride was prepared by pipetting out 0, 1, 2, 3, 4, and 5 ml of 2 nd standard stock solution in each 10 ml volumetric flask and the volume was made up to the mark with chloroform to get a concentration of 0, 5, 10, 15, 20, 25 µg/ml respectively. 1.5 Preparation of 0.1 N HCL 0.1 N HCl was prepared by pipetting out 0.85 ml of conc. HCL in 100 ml of volumetric flask and volume was made up to the mark with distilled water. The systematic study of the effect of the following variables was considered. 1.6 PRELIMINARY INVESTIGATION: A Cleaned and dried separating funnel capacity of 250 ml was taken. 10 ml of 0.1 N of HCl was added in each separating funnel. Into this 5 ml of the 0.04% of BTB was added. Then 5 ml of working standard solution containg 20 µg/ml was added in a separating funnel followed by 5 ml of chloroform was added to extract the drug from the mixture. Shake the funnels vigorously for 2 min. and then the reaction mixture was kept aside for 10 min for the clear separation of the phases and completion of reaction. A straw yellow colored chromogen was obtained. Corresponding reagent blank is prepared in the same manner omitting the drug in which no color was seen. 1.7 PARAMETER FIXATION: 1.7a Determination of λ max: An absorption maxima or λ max is the wavelength at which maximum absorption takes place. Determination of λ max helps to avoid any interfering impurities. The data obtained is shown in Fig 1 1.7b Stability of color: The influence of time for the maximum color development and stability of the colored species were studied. Procedure: A cleaned and dried separating funnel capacity of 250 ml was taken. 10 ml of 0.1 N of HCl was added in each separating funnel. Into this 5 ml of the 0.04% of BTB was added. Then 5 ml of working standard solution containg 0, 5, 10 µg/ml was added in a each separating funnel. 5 ml of chloroform was added in each separating funnel to extract the drug from the mixture. The funnels were shaken vigorously for 2 min. and then the reaction mixture was kept aside for 10 min for the clear separation of the phases and completion of reaction. Blank was prepared by same method omitting the drug. The chloroform layer was separated and the absorbance was measured against a reagent blank at a 414 nm, the results are recorded in Table 1 and graph is given in Fig 2 1.8 INVESTIGATION: 1.8a Effect of volume of BTB Indicator Procedure: Cleaned and dried 6 separating funnels capacity of 250 ml were taken. 10 ml of 0.1 N of HCl was added in each separating funnel. Into this 1, 2, 3, 4, 5 and 6 ml of the 0.04% of BTB was added in the in each separating funnel respectively. Then 5 ml of working standard solution containg 10 µg/ml was added in a each separating funnel. 5 ml of chloroform was added in each separating funnel to extract the drug from the mixture. The funnels were shaken vigorously for 2 min. and then the reaction mixture was kept aside for 10 min for the clear separation of the phases and completion of reaction. The chloroform layer was separated and the absorbance was measured against a reagent blank at a 414 nm, the results are recorded in Table 2 and graph is given in Fig 3 1.9 OPTICAL CHARACTERISTICS 1.9a Determination of Concentration range: For the spectrophotometric analysis, determination of the concentration range which obeys Beer-Lambert s law is necessary for accuracy and reproducibility. 1.9b Preparation of standard curve: A standard curve was prepared by using pure Oxybutynin chloride in the conc. of 2.5-12.5µg/ml and selecting the absorption maxima at 414 nm. Procedure: Cleaned and dried 6 separating funnels capacity of 250 ml were taken. 10 ml of 0.1 N of HCl was added in each separating funnel. Into this 5 ml of the 0.04% of BTB was added. Then 5 ml of working standard solution containg 0, 5, 10, 15, 20, and 25 µg/ml was added in a each separating funnel. 5 ml of chloroform was added in 4344

each separating funnel to extract the drug from the mixture. The funnels were shaken vigorously for 2 min. and then the reaction mixture was kept aside for 10 min for the clear separation of the phases and completion of reaction. The chloroform layer was separated and the absorbance was measured against a reagent blank at a 414 nm, the results are recorded in Table 3 and graph is given in Fig 4 1.10 VALIDATION PARAMETERS : 1.10a LINEARITY Cleaned and dried 6 separating funnels capacity of 250 ml were taken. 10 ml of 0.1 N of HCl was added in each separating funnel. Into this 5 ml of the 0.04% of BTB was added. Then 5 ml of working standard solution containing 0, 5, 10, 15, 20, and 25 µg/ml was added in a each separating funnel. 5 ml of chloroform was then added to extract the drug from the mixture. The funnels were shaken vigorously for 2 min. and then the reaction mixture was kept aside for 10 min for the clear separation of the phases and completion of reaction. The chloroform layer was separated and the absorbance was measured against a reagent blank at a 414 nm, the results are recorded in Table 3 and graph is given in Fig 5 1.10b ACCURACY Recovery studies by the standard addition method were performed to study the accuracy of the proposed method. Pre-analysed samples of Oxybutynin chloride (5 µg/ml) were spiked with 80, 100 and 120 % extra Oxybutynin chloride standard and the mixture were analysed with the proposed method. Accuracy was assessed as the % Recovery at each concentration level. Data obtained from accuracy study are given in Table 4 1.10c REPEATABILITY : Final conc. of standard solutions of Oxybutynin chloride contained 2.5, 5, 7.5 10 and 12.5 µg/ml after extraction were prepared and a spectrum was recorded. Absorbance was measured at 414 nm against blank. The absorbance of the same concentration solution was measured six times and RSD was calculated. The data obtain are given in Table 5. Repeatability data of sample are given in Table 6 1.10d LIMIT OF DETECTION (LOD) & LIMIT OF QUANTITATION (LOQ): The limit of detection and quantification of the drugs were calculated with the standard deviation and slope. The results obtains were given in Table 7 σ= standard deviation s= slope of the calibration curve 1.10e SPECIFICITY AND SELECTIVITY : Table 8 Specificity and Selectivity study Study Specificity Selectivity Oxybutynin chloride Specific Selective 1.10f REPRODUCIBILITY : Reproducibility is assessed by means of an inter-laboratory trial. The absorbance readings were measured at 404nm at different laboratory using another spectrophotometer and the values obtained were evaluated using %RSD to verify their reproducibility. The data obtain are given in Table 9 1.10g INTRA AND INTER DAY PRECISION : Variation of results within the day (intra day), variation of results between days (inter day) were analyzed. 4345

Intraday precision was determined by analyzing Oxybutynin chloride for three times in the same day at 414 nm. Inter day precision was determined by analyzing the drug different day for three days at 414nm. The data obtain are given in Table 10 1.11 ANALYSIS OF MARKETED FORMULATION: Oxybutynin chloride was procured from the local market as tablets of strength 15 mg and marketed with brand name of TROPAN. Preparation of sample solution:- 20 tablets were weighed and powdered properly using a mortar and pestle. Powder weight equivalent to 100mg was weighed and transferred to 100ml of volumetric flask and dissolved in chloroform and filtered through whatmann filter paper in 100ml volumetric flask and made up to mark with same solvent which give the solution of 1000µg/ml conc. Further dilution was performed to get a concentration of 10µg/ml. A Cleaned and dried separating funnel capacity of 250 ml was taken. 10 ml of 0.1 N of HCl was added in each separating funnel. Into this 5 ml of the 0.04% of BTB was added. Then 5 ml sample solution was added in a separating funnel followed by 5 ml of chloroform was added to extract the drug from the mixture. Shake the funnels vigorously for 2 min. and then the reaction mixture was kept aside for 10 min for the clear separation of the phases and completion of reaction. The absorbance was taken at 414 nm. The amount oxybutynin chloride was calculated by using standard curve. The data was given in Table 11 RESULTS AND DISCUSSION In This method Oxybutynin chloride was based on the formation of yellow colored ion paired complex between Oxybutynin chloride and bromothymol blue by exctractive colorimetric method, which showed maximum absorbance at 414nm. Fig 1 λmax of Oxybutynin chloride Model : SHIMADZU UV-Visible 1700. Band widthm : 2nm. Response : Medium. Measurement : 800-350 nm. No. of cycle : 1. Sample : Oxybutynin chloride λmax : 414 nm 4346

A study was carried out for almost all the parameter established by ICH guidelines to validate the analytical methods for a solid pharmaceutical dosage forms i.e., Linearity, Accuracy, Precision, Robustness, Range and detection limit. The probable Colorimetric reactions are as follows: Table 1 Stability of coloured species of Oxybutynin chloride SL. No. Final conc. Of the drug after extraction ( 5µg/ml) Time (Minutes) Absorbance at 414 nm 1) 5 0 0.493 2) 5 10 0.492 3) 5 20 0.492 4) 5 30 0.490 5) 5 40 0.489 6) 5 50 0.487 7) 5 60 0.481 8) 5 70 0.475 9) 5 80 0.472 10) 5 90 0.470 4347

Fig 2 Stability of colour Conclusion: The stability of colour was found to be stable for 1 hr. Table 2 Effect of volume of BTB indicator Sl. No. Volume of BTB Indicator (ml) Absorbance at 414 nm 1 1 0.123 2 2 0.178 3 3 0.247 4 4 0.359 5 5 0.491 6 6 0.427 Fig 3 Effect of volume of BTB indicator Conclusion The maximum absorbance was obtained at 5 ml of 0.04% of BTB 4348

Sl. No. Volume of the working standard solution added(0-25 µg/ml) Added Table 3 Absorbance of different conc. of Oxybutynin chloride obeying beer s law Concentration of the drug in 5 ml µg/5ml Final conc. Of the drug in the chloroform after extraction µg/5ml Absorbance at 414 nm 1) 5ml (0 µg/ml) 0 0 0 2) 5ml (5 µg/ml) 25 2.5 0.240 3) 5ml (10 µg/ml) 50 5 0.494 4) 5ml (15 µg/ml) 75 7.5 0.695 5) 5ml (20 µg/ml) 100 10 0.970 6) 5ml (25 µg/ml) 125 12.5 1.245 Fig 4 Absorbance of different concentration of Oxybutynin chloride obeying beer s law CONCLUSION The linearity of the Oxybutynin chloride was found to be within the conc. range of 2.5 to 12.5 µg/ml Table 4 Determination of Accuracy Amt. of sample Amt. of drug added Amt. of drug recovered % Recovery OXB OXB OXB µg/ml µg/ml µg/ml 0XB 5 4 3.92 98.08 5 5 5.01 100.2 5 6 5.98 99.72 Table 5 Repeatability data for Oxybutynin chloride at 414 nm Concentration 2.5 5 7.5 10 12.5 µg/ml µg/ml µg/ml µg/ml µg/ml 0.238 0.495 0.698 0.973 1.250 0.237 0.495 0.697 0.971 1.247 Absorption 0.237 0.493 0.695 0.970 1.246 0.236 0.492 0.696 0.972 1.248 0.237 0.493 0.695 0.972 1.247 0.236 0.493 0.694 0.970 1.246 Mean. 0.2368 0.4935 0.6958 0.9713 1.2473 Std. Dev. 0.000752 0.001224 0.001471 0.001211 0.001505 Coefficient variation 0.0032 0.0024 0.0021 0.0012 0.0012 % RSD 0.32 0.24 0.21 0.12 0.12 n = 6 determination 4349

Table 6 Repeatability of sample application data for Oxybutynin chloride Oxybutynin chloride Concentration 5 µg/ml 0.490 0.488 0.487 Absorption 0.485 0.488 0.489 Mean. 0.4878 Std. Dev. 0.001722 Coefficient variation 0.0035 % RSD 0.35 n = 6 determination Table 7 LOD AND LOQ LOD LOQ 0.0579 0.174 Table 8 Specificity and Selectivity study Study Specificity Selectivity Oxybutynin chloride Specific Selective Table 9 Reproducibility data for Oxybutynin chloride at 414 nm Conc. µg/ml Instrument 1 %RSD Instrument 2 %RSD Inference 5 0.490 ± 0.00223 0.45 0.493 ± 0.00298 0.66 Not significant difference * At 95% confidence interval Table 10 Intra day and inter day precision data for Oxybutynin chloride at 414 nm Conc. µg/ml Intra day (n=3) CV %RSD Inter day (n=3) CV %RSD 5 0.241 ± 0.001147 0.0047 0.47 0.240 ± 0.001403 0.0058 0.58 10 0.498 ± 0.002430 0.0048 0.48 0.496 ± 0.002561 0.0051 0.51 15 0.697 ± 0.002915 0.0042 0.42 0.695 ± 0.003187 0.0045 0.45 Table 11 Assay Results of Marketed Formulation Actual concentration Amount obtained of Formulation %OXB of OXB(µg/ml) OXB(µg/ml) Tablet 5 4.85 97% CONCLUSION A extractive colorimetric method was developed with bromothymol blue the absorbance of chromogen was to be maximum at 414 nm against the corresponding reagent blank and proposed method makes use of simple reagent, which an ordinary analytical laboratory can afford. The method was found to be simple, precise, economic and less time consuming. The method has been statistically evaluated and results obtained were accurate, precise and insensitive and free from the interferences of other additives present in the formulation. The proposed Colorimetric methods can be used for determination of Oxybutynin chloride in tablets. 4350

Table 12 Summary of parameters of spectrophotometry Parameter Result λmax(nm) 414 nm Beer s law limits (µg/ml) 2.5-12.5µg/ml Sandell s sensitivity (µg.cm 2 /0.001 Au) 0.2767 Regression equation (y=a+bc) Slope (b) Intercept (a) b=0.098 a=0.008 Correlation coefficient (r 2 ) 0.998 1) At Level-1 (80%)=98.08 % recovery 2) At Level-2 (100%)=100.2 3) At Level-3 (120%=)99.72 Repeatability (%RSD) 0.12 to 0.32 Limit of Detection (µg/ml) 0.0579 Limit of Quantitation (µg/ml) 0.174 Specificity Specific Selectivity Selective Reproducibility Instrument 1 (%RSD) Instrument 2 (%RSD) Precision (n=3) Intra day precision (%RSD) Inter day precision (%RSD) 0.45 0.66 0.42-0.48 0.45-0.58 Acknowledgement The author wishes to thanks mates who helped me lot for my work. And how can I forget staff of Srinivas College of pharmacy, Mangalore who suggest me in all way. REFERENCES [1] (a)en.wikipedia.org/wiki/oxybutynin (b) http://www.drugs.com/pro/oxybutynin.html (c)medicinenet,com/oxybutynin [2] K Shrikanth; KA Emmanuel; R Raju, Rasayan J of Chem. 2010,3(1),179-87 [3] VS Varma; AM Kaushal; S Garg, J of pharmaceutical and biological analysis 2004,36(3),669-74 [4] NE Wagieh; MA Hegazy; M Abdelkawy; EA Abdelaleem, Pak J Pharm Sci. Oct 2008,21(4),366-9. [5] R Massoud; G Federici; S Casciani, J Chromatogr B Biomed Sci Appl. Oct 1999,734(1),163-7 [6] A Suman; B Naveen; MV Ramana, Pharmacophore 2011, Vol. 2(2), 156-162 [7] ICH, Q2A Text on validation of analytical procedures, Oct, 1994. [8] ICH, Q3B Validation of analytical procedures: methodology, Nov, 1996. 4351